BRIEF published on 12/19/2024 at 23:10, 1 year 1 month ago BlackBerry Outperforms in Q3 of Fiscal Year 2025 Cash Flow Cybersecurity Growth BlackBerry Financials IoT Revenue Cylance Sale
BRIEF published on 12/19/2024 at 23:10, 1 year 1 month ago BlackBerry surperforme au troisième trimestre de l'exercice 2025 Des Flux De Trésorerie Croissance De La Cybersécurité Données Financières De BlackBerry Chiffre D'affaires IoT Vente Cylance
BRIEF published on 12/19/2024 at 22:35, 1 year 1 month ago GEE Group Announces Fiscal 2024 Results with Revenue Decline Amid Economic Uncertainty Economic Uncertainty Revenue Decline GEE Group Results Staffing Challenges Fiscal 2024 Financials
BRIEF published on 12/19/2024 at 22:35, 1 year 1 month ago Le groupe GEE annonce ses résultats pour l'exercice 2024 avec une baisse des revenus dans un contexte d'incertitude économique Baisse Des Revenus Incertitude Économique Résultats Financiers De L'exercice 2024 Résultats Du Groupe GEE Défis En Matière De Dotation En Personnel
BRIEF published on 12/19/2024 at 22:35, 1 year 1 month ago Gladstone Investment Corporation to Acquire Ricardo Defense Business Acquisition Department Of Defense Gladstone Investment Equity And Debt Ricardo Defense
BRIEF published on 12/19/2024 at 22:35, 1 year 1 month ago Gladstone Investment Corporation va acquérir Ricardo Defense Business Acquisition Investissement Gladstone Ministère De La Défense Défense Ricardo Capitaux Propres Et Dettes
BRIEF published on 12/19/2024 at 22:10, 1 year 1 month ago Optex Systems Holdings Reports 2024 Financial Performance Financial Results Revenue Growth Profit Increase Optex Systems Military Demand
BRIEF published on 12/19/2024 at 22:10, 1 year 1 month ago Optex Systems Holdings publie ses résultats financiers pour 2024 Résultats Financiers Croissance Des Revenus Systèmes Optex Augmentation Des Bénéfices Demande Militaire
BRIEF published on 12/19/2024 at 22:10, 1 year 1 month ago Protagonist Therapeutics to Present at J.P. Morgan Healthcare Conference Protagonist Therapeutics Rusfertide Icotrokinra Biopharmaceutical Development J.P. Morgan Conference
BRIEF published on 12/19/2024 at 22:10, 1 year 1 month ago Protagonist Therapeutics présentera ses produits à la conférence JP Morgan Healthcare Rusfertide Thérapeutique Protagoniste Icotrokinra Développement Biopharmaceutique Conférence De JP Morgan
Published on 01/26/2026 at 19:55, 1 hour 57 minutes ago Alta Copper Shareholders and Optionholders Approve Proposed Acquisition by Fortescue
Published on 01/26/2026 at 19:00, 2 hours 52 minutes ago Critical Elements Lithium Corp Announces Investor Relations Partnership With Adelaide Capital and Oak Hill Capital
Published on 01/26/2026 at 19:00, 2 hours 52 minutes ago Critical Elements Lithium Corp Annonces Un Partenariat en Matière De Relations Avec Les Investisseurs Avec Adelaide Capital and Oak Hill Capital
Published on 01/26/2026 at 18:55, 2 hours 57 minutes ago Kingsmen Resources Announces Upsize of Bought Deal Private Placement to Gross Proceeds of C$11 Million
Published on 01/26/2026 at 15:42, 6 hours 10 minutes ago Greenlane to Deploy up to 30 Million Units of BERA Into Validator Infrastructure to Participate in Protocol-Level Yield Mechanisms, Bringing Total Validator Deployment to up to 50 Million Units
Published on 01/26/2026 at 19:32, 2 hours 19 minutes ago GEA publishes preliminary figures and exceeds expectations for key financial indicators for 2025, confirms accelerated sales growth in 2026
Published on 01/26/2026 at 19:00, 2 hours 52 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 19 JANVIER 2026 au 23 JANVIER 2026
Published on 01/26/2026 at 18:56, 2 hours 55 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/26/2026 at 18:41, 3 hours 11 minutes ago EQS-Adhoc: The Platform Group: Intended Acquisition of the AEP Pharma Group with EUR 1 Billion in Profitable Revenue and a New Independent Business Segment
Published on 01/26/2026 at 18:30, 3 hours 22 minutes ago DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million
Published on 01/26/2026 at 18:00, 3 hours 51 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 20 et le 21 janvier 2026
Published on 01/26/2026 at 18:00, 3 hours 51 minutes ago Reporting on share buyback transactions carried out between January 20 and January 21, 2026
Published on 01/26/2026 at 17:45, 4 hours 7 minutes ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
Published on 01/26/2026 at 17:45, 4 hours 7 minutes ago Gimv verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen
Published on 01/26/2026 at 17:45, 4 hours 7 minutes ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
